Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Fortress Biotech (FBIO) PT Raised to $13 at Roth/MKM

August 14, 2024 5:06 AM EDT

Roth/MKM analyst Jason Whittes raised the price target on Fortress Biotech (NASDAQ: FBIO) to $13.00 (from $10.00) while maintaining a Buy rating.

The analyst comments "FBIO reported 2Q24 revenues down 14.4% to $14.9 million vs. consensus of $14.8 million and our estimate of $14.0 million. EPS was ($0.73) vs.... More

B.Riley Reiterates Buy Rating on Journey Medical Corp. (DERM)

August 13, 2024 6:55 AM EDT

B.Riley analyst Kalpit Patel reiterated a Buy rating and $8.00 price target on Journey Medical Corp. (NASDAQ: DERM).

The analyst comments "Journey Medical (DERMBuy, $8 PT) reported 2Q earnings, with top-line revenues of $14.9M (vs. our $13.3M estimate), likely signaling stabilization in its dermatology-focused... More